Advertisement
Advertisement
VERU
Veru Inc.
2.12
USDSponsored
+0.06
+2.91%
Nov 06, 15:59 UTC -5
Closed
After-Market
2.13
+0.01
+0.47%
Veru Inc. (VERU) Earnings
VERU Earnings Reports
Positive Surprise Ratio
VERU beat 21 of 37 last estimates.
57%
Next Report
Date of Next Report
Dec 15, 2026
Estimate for Q4 26 (Revenue/ EPS)
--
/-$0.30
Implied change from Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/-400.00%
Veru Inc. earnings per share and revenue
On Aug 10, 2026, VERU reported earnings of -0.30 USD per share (EPS) for Q3 26, beating the estimate of -0.32 USD, resulting in a 8.09% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +18.88% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 4 analysts forecast an EPS of -0.30 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nephros Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.02
Actual
$0.05
Surprise
+110.08%
Accendra Health, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.01
Actual
-$0.23
Surprise
-2,177.23%
Bio-Rad Laboratories, Inc.Class A
Report Date
Nov 04, 2026 For Q3 26
Estimate
$2.24
Actual
$2.65
Surprise
+17.92%
ICU Medical Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
$2.17
Actual
$2.44
Surprise
+11.93%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.36
Actual
$0.40
Surprise
+10.04%
Prestige Consumer Healthcare Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$1.08
Actual
$1.12
Surprise
+4.28%
Trulieve Cannabis Corp.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.07
Actual
$0.09
Surprise
+26.05%
PERRIGO COMPANY PLC
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.50
Actual
$0.60
Surprise
+18.44%
Phibro Animal Health Corporation Class A
Report Date
Nov 04, 2026 For Q1 27
Estimate
$0.81
Actual
$0.79
Surprise
-2.58%
Viemed Healthcare, Inc. Common Shares
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.12
Actual
$0.11
Surprise
-14.00%
FAQ
What were Veru Inc.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Veru Inc. reported EPS of -$0.30, beating estimates by 8.09%, and revenue of $0.00, 0% as expectations.
How did the market react to Veru Inc.'s Q3 2026 earnings?
The stock price moved up 18.88%, changed from $2.33 before the earnings release to $2.77 the day after.
When is Veru Inc. expected to report next?
The next earning report is scheduled for Dec 15, 2026.
What are the forecasts for Veru Inc.'s next earnings report?
Based on 4
analysts, Veru Inc. is expected to report EPS of -$0.30 and revenue of -- for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.